life sciences - een-portugal.pt
TRANSCRIPT
2013
Life Sciences
2
Portugal
aicep Portugal Global
Content
Life Sciences
PORTUGAL IS A BUSINESS OPPORTUNITY
Why choose
Portugal?
Strategic location
Portugal is the European nearest country to the U.S.
3-hour distance between Brazil and Russia.
Same time as UK and Ireland.
Why choose
Portugal?
Portugal 10,6
Iberian Market 51
European Market 494
Portuguese Speaking countries 220
Attractive Consumer Market
Million Inhabitants
Great and privilege economic relations
between Portugal and Brazil, Angola and
Mozambique.
Daily flights to major European cities.
Qualified Workforce
Flexible labour lawHigh-standard educationWide availabilityPartnerships with world-class US institutions
71,7%
42% At least 1 language
23% At least 2 languages
6% At least 3 languages
43,6
Working Days Lost
(per 1.000 employees – EIRO, 2005-
2009)
11,3
Portugal has a highly skilled and educated
workforce. Portugal ranks on Top within the
EU countries in number of PhDs per 1,000
inhabitants.
40% of students in tertiary education are
enrolled in engineering, sciences and health.
The increase rate in the last 3 years is about
30%.
Portuguese are known for commitment to
work which places us below the EU average
regarding working days lost per year.
Language skills: English, French and Spanish
are the most spoken languages. English is
universally taught from 1st grade.
Why choose
Portugal?
Competitive Costs
Portugal is still cost competitive according to international recognized
sources. There was a decrease of -1,2% in hourly labour costs in 2012
Q1 (Euro 27 rose by +2,0%).
In terms of real estate – industrial space - and within 53 countries/cities
worldwide, Portugal/Lisbon is the 8th less expensive location.
Portugal also has one of the lowest monthly minimum wage in Europe
(485€).
11,4 12,4
Electricity (Prices for industries in
€/100kWh – Eurostat 2012
S1)
3,4 4,0
Natural Gas (Prices for industries, in €/GJ –
Eurostat 2012 S1)
87 100
Cost of Living (HFC 2011 - Eurostat)
+1,5
Labour Cost Index (Year-on-year rate of change –
Eurostat 2012 Q1)
-1,2
Why choose
Portugal?
1,5
Technological Infrastructures
Why choose
Portugal?
Telecommunications have been
a major priority in Portugal. The
country has now 95% coverage
of broadband infrastructures.
The net increase in the
broadband penetration growth for
Portugal is above the OECD
average (Dec 2010).
The percentage of fiber connections in total
broadband is already 6% for Portugal,
ahead of countries such as Netherlands,
Finland, France, Spain, Italy, Poland,
Austria Germany or Belgium.
The Internet is also well developed.
Portugal is a United Nations case study in
terms of e-Government and its availability
of public services on-line.
0,38 0,72
Telecom Prices Euro/10 min call
Eurostat 2010
FULLY DIGITALIZED
Office Space available
Portugal offers a dynamic real estate market. High quality
space, well designed and energy efficiency oriented has
boomed and rent prices are competitive comparing the other
European countries.
Why choose
Portugal?
Occupancy cost, in €/sqm/year, C&W2011
Industrial space
123,5
52,2 79,2
Occupancy cost, in €/sqm/year, C&W2013
Office space
915
290 439
Portugal is ahead of
countries such as France
and Spain in terms o
cost. The figures are
shown for Lisbon. If we
considered Porto area,
prices can lower 25%.
The Technological parks spread all
over the country offer excellent
conditions to establish operations
in manufacturing, retail, services
or research. Major parks are
close to Universities or higher
education institutions and have
good roadway accessibilities.
Services offered:
• Meeting and conference rooms;
• Auditoriums;
• Education centers;
• Incubating facilities;
• Labs;
• Financial services;
• Private funding;
• Researchers from Universities;
• Parking area, restaurants, etc.
High-Tech Parks
Business friendly environment
Why choose
Portugal?
MULTI-CULTURAL
Portugal is very open to foreign cultures:
the availability of international schools,
the safety record and quality of life
attract expatriates.
As a result Portugal is ranked #2 in the
Migrant Integration Policy Index 2011.
“Portugal is unique in attracting young
graduates and executives.” Carlos
Brazão, Cisco Portugal
EASE OF DOING BUSINESS
• Major public services are on-line;
• Portugal is considered by the United
Nations, a case study in e-
Government;
• Average time to set up a firm is less
than 1-hour
They chose us
Why choose
Portugal?
Our decision is a result of the recognition of the hospitality and
the commitment of the Portuguese Government, of the multilingual skills of the
local population as well as its professionalism and ability, and proven success
in innovation areas.”
Chris Dedicoat, Senior Vice-President for Europe, Cisco
“
”
One of our main strategic lines was always to shorten
distances with the academic world and to bet in strong innovation,
investigation and development in Portugal thus taking advantage of the
Portuguese engineer’s excellence.
João Picoto, Chairman of Nokia Siemens Networks
Portugal
“
”
SERVICES MANUFACTURING
Life Sciences:
An Overview
Source: Health Cluster Portugal, 2011
OVERVIEW The Health Cluster in Portugal: an eco-system
Pharma & Biotech
Medical Devices
Healthcare
R&D Centers
Universities
/Education
Technological parks
Shared Services
Retail
Manufacturing
Services
IT
Regulatory Bodies Infarmed, Ministry of Health
CORE ACTIVITIES
Life Sciences in Portugal
• Turnover: 319 Million Euro
• Employment: 4,573
• Number of companies: 985
• Gross Value Added: 125 Million Euro
• Exports 2011: 209 Million Euro
• Exports 2012: 259 Million Euro
Pharma
Source: INE 2013, SCIE, Figures for 2011
CORE ACTIVITIES
• Turnover: 1,181 Million Euro
• Employment: 6,196
• Number of companies: 133
• Gross Value Added: 346 Million
Euro
• Exports 2011: 708 Million Euro
• Exports 2012: 728 Million Euro
The Health Cluster in Portugal: an eco-system OVERVIEW
Medical Devices
Healthcare
• Turnover: 11,211 Million Euro
• Total Employment: 247,630
• Number of companies: 82,303
• Gross Value Added: 5,028 Million Euro
• Increasing rate in the last 5 years: +24.3%
Industry sector
with relevant
weight in
employment and
value added.
Life Sciences in Portugal
PhDs in Portugal, by year (2001=100)
Investing in HR has been a major priority HR
247
212
50
100
150
200
250
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
PhD
s in P
ort
ugal 2001=
100
Health TOTAL
The allocation of scientific area is based on the Classification of Fields of Science - 2007 (FOS) in the English translation of the "Revised Classification of Fields
of Science and Techonology» Frascati Manual 2002, version May 2006.
Source: Statistical survey to the National Register of Themes PhD Thesis in Progress and Completed PhD Higher Education, GPEARI / MEC, DGEEC, 2011
Life Sciences in Portugal
2
4
6
8
10
2001 2003 2005 2007 2008 2009 2010 2011p
‰ a
ctive p
opula
tion
R&D - Human Ressources
Total RH Researchers
Source: Aicep
Champalimaud Foundation, a private
biomedical research center which aims to
support researchers working at the
cutting-edge of medical science. A special
focus on neuroscience research,
translational cancer research, and clinical
practice.
More at: www.fchampalimaud.org
International Iberian Nanotechnology
Laboratory is the first fully international
research organization in Europe in the
field of nanoscience, nanomedicine and
nanotechnology, with at least 200
researchers and 100 PhD students from
all over the world.
More at: www.inl.int/
R&D
Portugal hosts several recently- created world class R&D institutions of excellence.
Life Sciences in Portugal
Source: APBio
R&D
Portugal hosts several world class R&D institutions of excellence.
AIBILI - Association for Innovation and Biomedical Research on Light and Image
is a private non-profit organisation, founded in 1989, established to support technology
transfer to industry. AIBILI is dedicated to help the development of new products for
pharmaceutical and biotechnology companies, with special expertise in Ophthalmology.
BIOCANT is an applied research and development center that provides innovative
services of Biotechnology relevant to Life Sciences and promotes the development of
R&D in consortium with national and international companies to the creation of new
products and services. The Centre drives technology transfer between fundamental
research centres of known competence and biotech companies.
BIOCANT is the R&D centre of BIOCANT PARK, the first Portuguese technology park
dedicated to Biotechnology.
CNC - Center for Neuroscience and Cell Biology is a non-profit biomedical research
center at the University of Coimbra. CNC brings together scientists from the Faculties of
Science and Technology, Medicine and Pharmacy and from the University Hospital.
The CNC is structurally subdivided in ten departments (Cell Biology, Biophysics,
Biochemistry, Neurochemistry, Neuropharmacology, Molecular Biotechnology,
Neurobiology, Microbiology, Vectors and Gene Therapy, Graduate Studies and Advanced
Strategic Studies), each headed by a director, and the Laboratory of NMR.
Life Sciences in Portugal
Source: IBMC and APBIO
R&D
Portugal hosts several world class R&D institutions of excellence.
IBMC – Institute for Molecular and Cell Biology is a multidisciplinary research institution
that was formed in 1997 with the aim of bringing together researchers working within the
University of Porto and affiliated hospitals to produce a unique environment promoting
research in the life sciences.
IGC - Instituto Gulbenkian de Ciência’s scientific interests are focused on the genetic
basis of development and evolution of complex systems, privileging organism-centred
approaches in experimental models that include plants, yeast, flies and mice, and on the
genetics of complex human diseases. A strong theoretical sector (Estudos Avançados de
Oeiras) is one of the Institute’s specificities, the others being the quality of the services, and
a strong investment on international exchange in the form of graduate courses, workshops
and symposia.
IMM - Instituto de Medicina Molecular is a Non-profit Association, whose associate members are
the University of Lisbon, the University of Lisbon School of Medicine, the Santa Maria Hospital, the
Portuguese Institute of Oncology, the University of Lisbon Foundation, the Association for Research
and Development of the University of Lisbon Medical School, and the Oriente Foundation.
An important added value derives from the close interactions between IMM, the medical school and
the University hospital. These entities established a consortium to promote translational research by
providing a framework to develop pre-clinical research, clinical research and new technologies,
which is excellently positioned to disseminate new discoveries to university education, to the biotech
and pharmaceutical industry, and to medical practitioners
Life Sciences in Portugal
Source: APBIO
R&D
Portugal hosts several world class R&D institutions of excellence.
INEB - Instituto de Engenharia Biomédica, has four working Groups:
The Biointerface Group focus on the tissue-material interface, at cellular levels.
The Bioceramics and Glasses Group focus on the research to the development of novel synthetic bone
grafts for the treatment of clinical situations associated with bone trauma, bone disease and ageing.
The Biomedical Imaging and Vision Computing Group addresses the Image Analysis in Medicine and
Biology program and the Vision Computing and Biomedical Modelling.
The Signal Processing Group unites researchers in signals and systems engineering and clinical
monitoring.
IPATIMUP - Institute of Molecular Pathology and Immunology main goals are: research in human
pathology, with particular emphasis on oncobiology; training of graduate students, technicians,
residents and specialists in pathology; diffusion of scientific knowledge and teaching of undergraduate
students; providing sophisticated diagnostic expertise in the different fields covered by the Institute:
pathology, oncobiology and population genetics
ITQB - Instituto de Tecnologia Química e Biológica is a research institute of the Universidade Nova
de Lisboa. Its mission is to provide advanced training in an interdisciplinary environment through high
quality research work in Chemistry, Biology and associated technologies.
Since 2001, ITQB together with Instituto Gulbenkian de Ciência and Instituto de Biologia Experimental
e Tecnológica (IBET) constitutes an Associate Laboratory
Life Sciences in Portugal
PORTO UNIVERSITY
NOVA
UNIVERSITY
LISBON UNIVERSITY
MINHO UNIVERSITY
COIMBRA UNIVERSITY
ALGARVE UNIVERSITY
CATHOLIC UNIVERSITY
EDUCATION
Main Portuguese Universities with undergraduate
programs and R&D Institutions in Sciences & Health
AVEIRO UNIVERSITY
BEIRA INTERIOR UNIVERSITY
ÉVORA UNIVERSITY
TRÁS-OS-MONTES/ ALTO DOURO UNIVERSITY
INSTITUTO SUPERIOR TÉCNICO
Life Sciences in Portugal
Source: Aicep
In 2009, an International Cooperation
Program was launched between Medical
Schools in Portugal and the U.S. Harvard
Medical School to foster collaborative
clinical research in areas related to
human disease, and launch post-
graduate medical training.
MIT Portugal has launched the
Bioengineering Systems, a world-class
graduate program offered jointly by four
Portuguese universities focused in
physical, chemical and biological
engineering, computational systems, and
medical technologies.
Prestigious academic Institutions have chosen Portugal for partnerships on cutting
edge research and education.
EDUCATION
Life Sciences in Portugal
Source: http://www.fraunhofer.pt
EDUCATION
Prestigious academic Institutions have chosen Portugal for partnerships on cutting
edge research and education.
Fraunhofer Portugal in Oporto coordinates cooperation
between research institutes in Portugal with the
Fraunhofer Institutes in Germany and manges the
Fraunhofer Research Center for Assistive Information
and Communication Solutions in conjunction with the
University of Porto.
Life Sciences in Portugal
Did you know?
Several Portuguese
scientists have been
awarded by Gates
Foundation for outstanding
work in Malaria.
[November 11, 2010]
In 2012 round of Howard
Hughes Medical Institute
Grants, five out 28 grants
were awarded to
Portuguese scientists.
Major foreign companies also chose Portugal
PLAYERS
Life Sciences in Portugal
BIAL, Portuguese largest pharmaceutical company, invests
20% of its revenues in R&D for new medicines. The company
has 6 new worldwide patented molecules and sells its
medication in more than 30 countries. Main areas are:
musculoskeletal system, central nervous system,
cardiovascular diseases, antibiotic therapy, respiratory
diseases, immunotherapy.
BIAL
LATEST NEWS
BIAL Foundation has the goal to encourage the scientific study
of the human being. Through the BIAL award and grants, BIAL
has analyzed 518 projects and mobilized 1,156 researchers and
has distinguished 227 authors .
MAIN PLAYERS
Life Sciences in Portugal
Labesfal is the biggest manufacturer of medicines for
hospital use and market leader in several products. Its
state of the art facilities at Santiago de Besteiros,
integrating 4 production units in 3 independent buildings
with floor area of more than 38.000 m2
Since 2005 Labesfal is 100% subsidiary of Fresenius Kabi.
Fresenius Kabi provides: Infusion Therapy, Parenteral
Nutrition, Enteral Nutrition, Infusion Technology,
Transfusion Technology and Ambulatory Care.
LABESFAL – FRESENIUS KANI MAIN PLAYERS
FAST FACTS
Revenues: €128.5
Mn (2012)
Jobs: 500
Exports: 67%
40 destination
countries
For the second time Labesfal was distinguished in 2011
as “the Best Pharmaceutical Company” by the
Portuguese magazine “Exame”.
Life Sciences in Portugal
Hovione is an international group dedicated to the cGMP
development and manufacture of APIs, serving exclusively
the pharmaceutical industry. With FDA inspected plants in
Europe, the Far East and the US, Hovione has a 50-year
track record committed to the highest levels of service and
quality.
HOVIONE MAIN PLAYERS
FAST FACTS
Revenues: US$
180 Mn (2011)
Jobs: 1,100
Nº of sites: 5
(China, Portugal,
Ireland, USA)
Life Sciences in Portugal
ATRAL-CIPAN and CGC GENETICS MAIN PLAYERS
AtralCipan is a Portuguese leader pharmaceutical group in the
development, scale-up, manufacturing and commercialisation of
Active Pharmaceutical Ingredients (API) and Finished Dosage
Forms (FDF).
AtralCipan develops an integrated marketing activity, for the
national and international markets, granting its presence in several
health areas, including veterinary, otc and parapharmacy products
CGC Genetics has been the
leading provider of specialty
genetic tests in Portugal and has
grown into one of Europe’s major
clinical laboratories. The
company offers more than 1,500
genetic tests covering all major
medical disciplines including
prenatal screening and
diagnosis, hematology, oncology,
neurology, cardiology, preventive
medicine, common and rare
diseases and pharmacogenetics.
LATEST NEWS
Life Sciences in Portugal
“50 years experience in industrial fermentation
capacity over 850 000 liters”
Software & Pharmaceutical MAIN PLAYERS
ALERT is a comprehensive suite for healthcare software
solutions from the point of care to the patient’s home and
everything between, including EMR, HIE, PHR, BI and
CRM. With 8 sites across the world, software is available
in major languages, thus enabling to target almost any
major market. For instance, the length of triage process
can be reduced up to 70%.
BLUEPHARMA, a FDA certified company is a
Portuguese Pharmaceutical based in Coimbra. It
produces pharmaceutical drugs and generics and has
a strong investment in Research, Development and
registration of pharmaceutical drugs.
In 2010 it wan the International Quality Award, a
distinction granted internationally by the several
chambers of commerce and embassies. Bluepharma's
strong investment in R&D was recognized by the
National Ranking for Scientific and Technologic
Potential, promoted by the Ministry of Science and
Technology, which places it in 2nd place among all
pharmaceutical companies.
Life Sciences in Portugal
Medical Devices MAIN PLAYERS
Fapomed is dedicated to the
production of single use
medical devices, such as
surgical gowns, surgical
covers, drapes and CPT
(Custom Procedure Trays)
either sterile and non- sterile.
Fapomed employs around
200 people and has 2
factories in Portugal and it
has recently opened a
factory in Ukraine.
Fapomed®, Steribata®,
Sterikit®, Accuro®,
Cirgikit®, Safetray® are
international registered
trade marks owned
by Fapomed, SA.
Bastos Viegas is the main Portuguese producer and
supplier of Non Active Medical Devices. The
company products are in over 80 countries
distributed by the 6 continents.
In parallel, it represents
in Portugal many
international brands of
Medical Devices for the
wholesale distribution in
the national market.
The retail distribution is
made under the
registered brands
Medical Express and
Bel Express, in whose
catalogues there are
more than 10.000
references.
Life Sciences in Portugal
Pharmaceutical MAIN PLAYERS
Grupo Azevedos is among
the most solid
pharmaceutical groups in
Portugal. The company
offers contract
manufacturing, licensing-
out OTC products,
distribution agreements for
innovative prescription
and OTC products and
regulatory and
promotional services.
Grupo Azevedos
employs around 600
people, an annual
turnover of 140 M€ and
production and
distribution sites in 20
locations around the
world.
Tecnimede Group is a key player in
Generic Medicines. It develops new
pharmaceutical forms, including modified
release forms and sterile forms,
production of oral solid pharmaceutical
forms and scaling-up, validation of
processes. •Employment: 542
•Turnover: 100 M€
•Exports: 20%
•R&D Expenses: 15% sales
Life Sciences in Portugal
Fresenius Kabi Group (Labesfal unit) recently announced a new
investment project for adopting new technologies applied to production,
logistic and distribution. It also allows the company to introduce new
products such as EAS, Quetiapina e Montelukas. The project amounts to 8
M€, creates 27 new jobs and retains the existing 469.
Recently, three R&D projects were announced by the company intended
to research new therapies for epilepsy, neuropathic pain (new
Eslicarbazepine acetate solutions) and Parkinson disease.
Total Investment: 130M€
New jobs: 43
Retained jobs: 250
Recent Investment Track Record
Life Sciences in Portugal
aicep Portugal Global
We are a Business Development Agency, focused on
the development of a competitive business
environment that contributes to the international
expansion of the Portuguese Economy.
Who are we?
Increasing the country’s competitiveness,
promoting large private investment and fostering
the internationalization of Portuguese companies. Mission
Values
Focus on clients. We serve our clients in accordance to their requirements
through various solutions and long-term relationships.
Selectiveness. We direct our activity towards projects and markets that
make a better contribution to company competitiveness and the
sustainability of the Portuguese economy.
Excellence. We seek to exceed expectations by means of a rigorous
approach, effectiveness, enthusiasm and a willingness to innovate.
aicep Portugal Global
About Us
aicep Portugal Global: how can we help
you?
1
Pre- Investment
2
Incentives
Negotiation
3
Settling In
4
After Care
Promoting a direct negotiation
with companies, through which a
tailored approach to incentives
may be applied in order to define
a global package that fully
satisfies the investor's needs
Single point of contact
in all phases: pre-
investment, incentives
negotiation, settling in
and after care
Government
business entity,
flexible, free of
charges and
streamlined services
Dynamic
approach
focused on the
client or investor
www.portugalglobal.pt